Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)

INTRODUCTION: The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for Glomerulonephritis recommend that patients with membranous nephropathy (MN) at risk for progression receive immunosuppressive therapy (IST), usually after 6 months of observation. A cyclophospha...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Shaughnessy, Michelle M., Troost, Jonathan P., Bomback, Andrew S., Hladunewich, Michelle A., Ashoor, Isa F., Gibson, Keisha L., Matar, Raed Bou, Selewski, David T., Srivastava, Tarak, Rheault, Michelle N., Al-Uzri, Amira, Kogon, Amy J., Khalid, Myda, Vento, Suzanne, Sanghani, Neil S., Gillespie, Brenda W., Gipson, Debbie S., Wang, Chia-shi, Parsa, Afshin, Guay-Woodford, Lisa, Laurin, Louis-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895579/
https://www.ncbi.nlm.nih.gov/pubmed/31844809
http://dx.doi.org/10.1016/j.ekir.2019.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895579/
https://www.ncbi.nlm.nih.gov/pubmed/31844809
http://dx.doi.org/10.1016/j.ekir.2019.09.005

Ejemplares similares